At a glance
ClinicalIndex Comparison RecordN/AUnknown· 150 target
Drug / intervention
Insertion of ILR devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparative Analysis in Detection of Atrial Arrhythmia and Electrogram Quality in Three Different Insertable Cardiac Monitors
Kansas City Heart Rhythm Research Foundation·interventional·Posted Jul 15, 2020·Updated Sep 23, 2021
In Brief
A clinical study evaluating Insertion of ILR device for Arrhythmias, Cardiac. Targeting 150 participants across 1 site.
Detailed Summary
Comparative analysis of available ILR devices models Abbot Confirm RxTM, Medtronic Reveal LINQTM, and Biotronik BIOMONITOR., evaluating detection performance and effective of transmission of these devices to better understand the differences between them.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmias, Cardiac
CountriesUnited States
Collaborators--
Timeline
N/AUnknownOverdue
202120222023202420252026
First PostedJul 2020
Enrollment StartSep 2020
Primary CompletionDec 2021
Study CompletionMar 2022
TodayJul 2026
First PostedJul 15, 2020
Enrollment StartSep 21, 2020
Primary CompletionDec 1, 2021
Study CompletionMar 1, 2022
TodayJul 1, 2026
Enrollment to primary: 1.2 yearsPosted 6.0 years ago
Interventions
Insertion of ILR devicedevice
All patients enrolled will be randomized to have one of three ILR devices implanted (BIOMONITOR III, Reveal LinQ, or Confirm RX) and will be given event monitoring device for concurrent evaluation.